Report : Europe Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Biodegradable and Non-Biodegradable), Material [Calcium Hydroxylapatite, Hyaluronic Acid, Collagen, Poly-L-Lactic Acid, Polymethylmethacrylate (PMMA), Fat Fillers, and Other Materials], Application (Facial Line Correction Treatment, Lip Enhancement, Face Lift, Scar Treatment, and Others), and End user (Multispecialty Hospitals, Dermatology Clinics, Ambulatory Surgical Centers, and Other End Users)
The biodegradable segment by product is estimated to lead the market growth during the forecast period.
According to a new market research study of “Europe Dermal Fillers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Material, Application, End User and Country.” The Europe dermal fillers market is expected to reach US$ 2,589.75 million by 2028 from US$ 1,230.96 million in 2021; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028. The report highlights trends prevailing in the Europe dermal fillers market and the factors driving market along with those that act as hindrances.
The Europe dermal fillers market is expected to reach US$ 2,589.75 million by 2028 from US$ 1,230.96 million in 2021; it is estimated to grow at a CAGR of 11.2% from 2021 to 2028. The growth of the market is attributed to the factors such as preference for minimally invasive procedures, growth in population of age 30–65 years, and rise in the attraction of consumers toward beauty and wellness. However, the high cost of surgeries hinders the market growth.
People from the age group 30–65, struggling with the signs of aging such as lack of skin elasticity, wrinkles, and dark spots, are the major target of the dermal filler market players. According to the Central Intelligence Agency, in 2018, ~39.9% of the total German population belonged to the age group 25–54, while ~15.0% of the population belonged to the age group 55–65. Women of age 40–54 are the prime adopters of get dermal filler treatments. The younger age brackets make up a much smaller portion of the population pursuing dermal fillers. Also, long work hours and changing lifestyle have contributed significantly to rising levels of stress, resulting in several issues on the exterior appearance, especially on the skin and hair. Also, the increasing level of pollution shows detrimental effects on an individual’s physical appearance. Thus, international grooming products and at-home services have gained popularity to a great extent. Shifting focus on appearance has significantly increased the demand for beauty and dermatology products across the world. Premium beauty brands are now offering additional services, such as skin diagnosis, at their outlets to attract customers. Furthermore, the number of specialty skin clinics offering target treatments for various skin issues has also ramped up in recent years. In addition, the beauty industry is growing rapidly as the millennial women, of aged 25–34, are increasingly purchasing cosmetic products. Thus, the increasing acceptance of beauty devices and products among both men and women is likely to be a prevalent trend in the Europe dermal fillers market in the coming years.
In Europe, the rising cases of COVID-19 are expected to have a significant short-term negative impact on the medical aesthetics market. The pandemic particularly affected the medical cosmetics industry as many of the services and products from this category come under the non-essential and elective services. Due to lockdowns, the sector witnessed disruptions in supply chains due to limitations on import and export, discontinuation of flights, reduced production, and disturbed supply channels. Thus, decreased purchasing power of consumers due to personal and financial losses compelled people to deprioritize aesthetic services. Also, various cosmetics facilities and clinics in European countries were close for more than 3 months and suffered significant losses in revenue generation. According to the report published by Hamilton Fraser with the help of the National Health Service (NHS), more than 80% of clinics in the UK were closed during the lockdown, which led to 86% decrease in revenue.
The Europe dermal fillers market, by product is segmented into biodegradable and non-biodegradable. The Europe dermal fillers market, by material is segmented into calcium hydroxylapatite, hyaluronic acid, collagen, poly-l-lactic acid, polymethylmethacrylate (PMMA), fat, and other materials. Based on application, the Europe dermal fillers market is segmented into facial line correction treatment, lip enhancement, face lift, scar treatment, and others. Based on end user, the Europe dermal fillers market is segmented into dermatology clinics, multispecialty hospitals, ambulatory surgical centers, and others. Geographically, the Europe dermal fillers market can be sub-segmented into UK, Germany, France, Italy, Spain and Rest of Europe.
BIOXIS pharmaceuticals, TEOXANE LABORATORIES, AbbVie Inc., Galderma, Merz Pharma, Suneva Medical, HUADONG MEDICINE CO., LTD, and Prollenium Medical Technologies are among the leading companies operating in the Europe dermal fillers market.